109 related articles for article (PubMed ID: 31839034)
1. [Clinical Biological Characteristics and Prognostic Factors of Children with Ph
Liu ZY; Sun Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1754-1760. PubMed ID: 31839034
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic factors of pediatric patients with Ph-positive acute lymphoblastic leukemia].
Xue YJ; Wu J; Zuo YX; Jia YP; Lu AD; Zhang LP
Zhonghua Xue Ye Xue Za Zhi; 2018 Mar; 39(3):219-224. PubMed ID: 29562467
[No Abstract] [Full Text] [Related]
3. [Molecular response and prognostic factors of patients with Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia treated by imatinib with chemotherapy].
Wang J; Huang X; Jiang B; Qin Y; Bao L; Jiang H; Chen H; Jia J; Yang S; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):120-5. PubMed ID: 24606652
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic Efficacy of VICP+L-ASP/TKI on Adult Patients with B-ALL].
Shen MF; Wei JY; Yu WJ; Wang JH; Tong HY; Meng HT; Mai WY; Qian WB; Jin J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1730-1736. PubMed ID: 28024485
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of Factors Influencing Prognosis of 87 Adults with Ph Chromosome Negative ALL].
Li J; Zhang ZB; Liu ZR; Yang M; Nie YX; Wu MM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1011-1015. PubMed ID: 30111399
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of Clinical Characteristics and Therapeutic Efficacy in 61 Adult Patients with Acute Lymphoblastic Leukemia].
Zhang XP; Chen BA; Ge Z; Liu R; Ma XY; Gao C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):711-717. PubMed ID: 28641623
[TBL] [Abstract][Full Text] [Related]
7. [Application of imatinib in BCR- ABL positive acute lymphoblastic leukemia treatment in the real world].
Wan YL; Wang Y; Liu BC; Liu X; Gong XY; Zhao XL; Wang TY; Jiang EL; Feng SZ; Han MZ; Qiu LG; Mi YC; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2016 Oct; 37(10):886-891. PubMed ID: 27801322
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and laboratorial analysis for 15 adult cases of mixed phenotypic acute leukemia with Ph chromosome and/or positive BCR-ABL].
Yan LZ; Chen SN; Ping NN; Wang QR; Liu H; Ding ZX; Zhu MQ; Liang JY; Liu DD; Cen JN; Pan JL; Qiu HY; Sun AN; Wu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1116-20. PubMed ID: 24156417
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of Clinical Outcomes between P190 and P210 Trans-cripts in Adult Ph Chromosome Positive Acute Lymphoblastic Leukemia in the New Era of TKI].
Qiu LL; Lu YJ; Jing Y; Yu L; Liu DH; Wang LL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):369-74. PubMed ID: 27150994
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic significance of Ph-positive acute lymphoblastic leukemia].
Zhou L; Hu J; Chen J; Du S; Wang A; You J; Wu W; Shen Z; Li J
Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):109-13. PubMed ID: 24606650
[TBL] [Abstract][Full Text] [Related]
11. [Clinical Features and Prognostic Factors of Children with Acute Lymphoblastic Leukemia in High-Risk Group].
Zhang SH; An FY; Xu JX; Kong LJ; He HL; Chai YH; Zhao WL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):365-370. PubMed ID: 28446276
[TBL] [Abstract][Full Text] [Related]
12. Treatment of elderly patients with acute lymphoblastic leukemia--evidence for a benefit of imatinib in BCR-ABL positive patients.
Brandwein JM; Gupta V; Wells RA; Schuh AC; Schimmer AD; Lipton JH; Messner HA; Yi QL; Chun K; Kamel-Reid S; Minden MD
Leuk Res; 2005 Dec; 29(12):1381-6. PubMed ID: 15927253
[TBL] [Abstract][Full Text] [Related]
13. [Clinical Efficacy of ALL-2005 and ALL-2009 Regimen and Factors Influencing Prognosis of Newly Diagnosed ALL Patients Aged between 10-18 Years Old].
Li X; Si SY; Cai JJ; Qu WJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1904-1911. PubMed ID: 33283718
[TBL] [Abstract][Full Text] [Related]
14. [Multicenter clinical trial of acute lymphoblastic leukemia in elder children and adolescents].
Zhang N; Shen SH; Wang NL; Li H; Yang JW; Shao JP; Jiang H; Tang JY
Zhonghua Xue Ye Xue Za Zhi; 2018 Sep; 39(9):717-723. PubMed ID: 30369180
[No Abstract] [Full Text] [Related]
15. [Clinical and laboratory characteristics of 12 Ph/BCR-ABL positive acute myeloid leukemia patients].
Cai W; He X; Chen S; Sun A; He J; Zhu M; Wu D
Zhonghua Xue Ye Xue Za Zhi; 2015 May; 36(5):398-402. PubMed ID: 26031527
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of treatment response and prognostic factors of T-LBL patients treated with pediatric-like ALL therapy following HSCT].
Wang HT; Dong Y; Gao XT; Wan Z; Zhao YX; Liu YM; Liu L
Zhonghua Xue Ye Xue Za Zhi; 2020 May; 41(5):387-393. PubMed ID: 32536135
[No Abstract] [Full Text] [Related]
17. [Clinical Characteristics of Patients with Ph
Jia YN; Li Y; Gong XY; Liu KQ; Ye L; Wang HJ; Li QH; Li CW; Wang Y; Wang JX; Mi YC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):354-359. PubMed ID: 30998137
[TBL] [Abstract][Full Text] [Related]
18. [Clinical study of Philadelphia chromosome-positive adult acute lymphoblastic leukemia].
Zhang YF; Chen ZM; Lou JY; Ni WM; Wang YG; Meng HT; Tong HY; Qian WB; Jin J
Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):814-8. PubMed ID: 22339953
[TBL] [Abstract][Full Text] [Related]
19. Early MRD response as a prognostic factor in adult patients with acute lymphoblastic leukemia.
Šálek C; Folber F; Froňková E; Procházka B; Marinov I; Cetkovský P; Mayer J; Doubek M;
Eur J Haematol; 2016 Mar; 96(3):276-84. PubMed ID: 25997106
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of clinical efficacy between first-generation and second-generation tyrosine kinase inhibitors based regimen in the treatment of patients with BCR-ABL positive acute lymphoblastic leukemia].
Liu Y; Mi RH; Chen L; Yuan FF; Yin QS; Fu YW; Zhu XH; Liu XJ; Zhang YL; Zhang WL; Wei XD
Zhonghua Xue Ye Xue Za Zhi; 2019 Sep; 40(9):738-743. PubMed ID: 31648474
[No Abstract] [Full Text] [Related]
[Next] [New Search]
